CD8A and neoplasm: Although the ICD-induced anti-tumor response ultimately relies on CD8+ T cells, intact toll-like receptor 4 (TLR4) signaling in tumor-infiltrating innate immune cells, such as DCs, is required since the danger signals or TLR agonists are first perceived by innate immune cells.